What is Cromatic?
Cromatic Inc., established in 2022, is at the forefront of accelerating research and development within the biotechnology sector. The company offers an intuitive digital marketplace designed for project outsourcing, enabling biotech firms to efficiently identify and engage with suitable Contract Research Organizations (CROs). Cromatic's cloud-based platform streamlines the entire outsourcing process, from initial identification to project completion, through integrated task management software that facilitates communication, milestone monitoring, and overall project oversight.
How much funding has Cromatic raised?
Cromatic has raised a total of $5.3M across 1 funding round:
Other Financing Round
$5.3M
Other Financing Round (2023): $5.3M with participation from WorkLife Ventures, AgFunder, What If Capital, and FJ Labs
Key Investors in Cromatic
WorkLife Ventures
WorkLife Ventures is a venture capital firm that likely focuses on investments within the broader scope of work-life integration and productivity tools, potentially extending to operational efficiency platforms for various industries.
AgFunder
AgFunder VC is a global venture capital firm specializing in the agrifood and healthtech sectors, with a strong emphasis on deep technologies like AI and biotech. They invest in companies driving sustainable growth and addressing systemic challenges in food and agriculture.
What If Capital
What If Capital is an investment firm with a notable focus on mental health startups, aiming to improve access to care through innovative treatments and digital health solutions. Their interests may also span disruptive healthcare technologies.
What's next for Cromatic?
With this substantial enterprise-level investment, Cromatic is poised for accelerated growth and market expansion. The strategic nature of the recent financing indicates a focus on solidifying its position as a key enabler for biotech R&D. Future developments are likely to involve enhancing platform capabilities, expanding its network of CROs, and potentially exploring new verticals within scientific outsourcing. This capital infusion will be critical in scaling operations and further optimizing the digital marketplace for biotech project management.
See full Cromatic company page
